MBP134

DB18686ExperimentalProtein Based Therapies

MBP134 is a pan-ebolavirus cocktail comprising two broadly neutralizing human antibodies. It is under investigation for the treatment of Sudan ebolavirus (SUDV).

Mechanism
Curator reviewed
Code names
MBP-134

Resolves to

Targets

What you can answer from here — as of November 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with MBP134, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account